$1,999.99 $1,599.99 Buy It Now or Best Offer, $425.00 Shipping, 30-Day Returns, eBay Money Back Guarantee
Seller:vast_trades✉️(3,895)98.6%,
Location:Ridgefield, Washington, US,
Ships to: WORLDWIDE,
Item:285405839799Nanogen NanoChip 400. Information taken direct from the manufacturer- "About Nanogen, Inc.
Nanogen develops advanced diagnostics to provide physicians and patients
worldwide more information to better predict, diagnose and treat disease.
The availability of new biomarkers is driving the evolution of medicine, and
Nanogen’s vision is to lead the development and growth of advanced
diagnostic testing in support of the movement towards individualized
healthcare by commercializing a comprehensive portfolio of differentiated
products. Diagnostics such as Nanogen’s and those marketed by its
subsidiary SYNyX that bring to light information about individuals’ genetic as
well as proteomic makeup are facilitating the shift to proactive versus
reactive healthcare.
Nanogen delivers a variety of products to clinical labs, research institutions
and point-of-care testing facilities. These customers are increasing their
demand for accurate and reliable diagnostic tools to create a range of tests.
These range from single, real-time tests to complex, molecular tests
performed on Nanogen’s microarray systems.
As a pioneer of nanotechnology and miniaturized biotechnology, Nanogen
expects its broad intellectual property portfolio will have diverse
applications and licensing opportunities in the future for medical diagnostics
as well as other markets.
The Opportunity: Molecular Diagnostics
Nanogen’s broad suite of diagnostic products makes it possible for the
company to take advantage of opportunities in the rapidly growing
molecular diagnostics industry. The molecular diagnostics market today is
estimated to be approximately $1 billion and is expected to grow at a
healthy pace of 30 - 50 percent per year. This growth is fueled by a better
understanding of the molecular basis of disease and the need for more
genetic tests to improve the prognosis and treatment of patients.
Business Strategy
Nanogen’s strategy is to identify and
commercialize diagnostic tests that meet
significant market needs. The company bolstered
its capital structure and initiated a business
development program to grow its revenue base.
The 2004 acquisition of SYNyX provided Nanogen
with a variety of point-of-care tests to
immediately add to its product portfolio. Later
last year, the merger with Epoch Biosciences
augmented the product line with 25 complementary analyte specific
reagents (ASRs) and other technologies for genetic analysis. These products
further leverage Nanogen’s existing sales and marketing infrastructure.
Nanogen will continue to identify large volume as well as unique tests with
a focus on moving the diagnostic process and information closer to the point
of physician and patient interaction. Nanogen will distribute its products
around the world through licensing and distribution agreements as well as
direct sales efforts to continue to expand its business into new and growing
markets in the U.S., Canada and abroad. Products: Addressing Labs’ Needs
Molecular Diagnostics & Genetic Testing
Available in 2005, the NanoChip® 400 is Nanogen’s second generation
advanced molecular diagnostic testing and development platform for clinical
research and clinical reference laboratories. The automated multi-purpose
system facilitates detection of known genetic sequences using a 400-site
NanoChip® Electronic Microarray. The NanoChip® 400 offers increased
throughput for running multiplex molecular assays on a smaller sized
instrument.
Nanogen’s suite of consumable products includes analyte specific reagents
(ASRs) for laboratories to develop very simple tests for single mutations or
more complex tests for multiple genetic markers. The merger with Epoch
Biosciences bolstered Nanogen’s line of ASRs by adding 25 complementary
products, allowing Nanogen to offer a broader suite of solutions to its current
and targeted customers. These MGB EclipseTM Detection Reagents are
compatible with many standard real-time PCR instruments for amplification
and quantitation of samples. Nanogen’s internally developed ASRs utilize the
NanoChip® microarray for more complex analysis of multiple markers. For
example, in 2005 the company will market a panel optimized for use with the
NanoChip® 400 that detects the six most common respiratory viruses.
The first generation, open platform NanoChip® Molecular Biology
Workstation is a resource for researchers identifying the next set of
mutations that could be useful as clinical assays. The system’s ability to test a
user defined set of mutations, called panels, on one chip makes it easier and
more cost-effective to use than research-grade thousand-gene chip arrays.
NEXUSdx™ Point-of-Care Diagnostics
NEXUSdx™ point-of-care diagnostic tests are marketed to healthcare
professionals and research facilities in Europe and Canada by Nanogen’s
subsidiary, SYNyX. The highly specialized products diagnose disease at the
initial stages to allow for earlier treatment as well as to monitor treatment
effectiveness and disease progression. Building expertise in cardiac related
health conditions, SYNyX plans to offer an NT-proBNP diagnostic test for
congestive heart failure in 2005. Analysts predict the BNP market will have
above-average growth and will reach approximately $300 million by 2005 as
use increases internationally.
Using its Proteomics Discovery Platform™, SYNyX scientists have identified
biomarkers in stroke, insulin resistance, type II diabetes, congestive heart
failure, Alzheimer's disease and traumatic brain injury. These discovery
efforts provide a deep pipeline of potential new and important products for
the point-of-care market.
Electricity is what makes the NanoChip®
different and is a key technological
advantage. At the heart of Nanogen's
technology is a tiny silicon chip called the
NanoChip® Electronic Microarray. The
NanoChip® 400 has 400 test sites upon which
genetic tests can be conducted. DNA and RNA
are moved and concentrated by controlling
the current at each test site, improving
accuracy, speed and flexibility. Comes as you see. Condition is used and shows minimal signs of use in a working environment. Removed from service in working condition. Does not come with any cables or software other than power cable.In effort to ship item with minimal chance of damage, we will be shipping via freight. Item will be palletized. When purchasing, please provide business name and shipping address that either has a loading dock or forklift so we can keep shipping costs down for you
Condition:Used
Condition:Comes as you see. Condition is used and shows minimal signs of use in a working environment. Removed from service in working condition. Does not come with any cables or software other than power cable.